Generative AI (Gen AI) is transforming industries at an unprecedented pace, and the pharmaceutical sector is no exception. With the surge of AI-driven innovations, data integrity has become a top priority. Gartner reports that 85% of AI projects falter due to poor data quality, and by 2025, AI will be responsible for creating 10% of the world’s data. For the pharmaceutical industry—where precision, compliance, and regulatory demands are paramount—advanced Master Data Management (MDM) is essential to keep pace with these new developments.
Yet MDM has long been overlooked, relegated to the background of business innovation efforts. Bluestonex has listened and is reshaping the MDM landscape with the October update to Maextro, designed specifically to bring MDM into the Gen AI era.
This update introduces a suite of transformative features aimed at enhancing user experience and delivering AI-optimized capabilities to streamline data management.
What’s New in Maextro?
- MS Teams AI Integration: With AI-powered insights built directly into Microsoft Teams, collaboration on tracking, reporting, and data processing is faster and simpler—ideal for complex, cross-functional pharmaceutical workflows.
- Enhanced Home Screen UI: Designed with a user-first approach, the new interface improves navigation, making data access and insights readily available for life sciences professionals.
- Usage & Adoption Reporting: Detailed insights into platform adoption help organisations measure performance, drive effective MDM strategies, and ensure compliance.
- Advanced Request Tracking: Enhanced automation and clarity provide more control over data requests, ensuring precise tracking that meets industry standards.
- New Reporting Logs: Detailed logs support transparency, vital for audit trails and regulatory adherence in the pharmaceutical sector.
- Improved Load Times and Interface Responsiveness: Smoother, more intuitive UI experiences keep users focused on data rather than interface issues, essential in fast-paced environments.
Why Gen AI Matters for MDM in Pharmaceuticals
For the pharmaceutical industry, data management quality has a direct impact on everything from regulatory compliance to R&D insights. As Gen AI continues to expand, the need for advanced, AI-integrated MDM becomes urgent. At Bluestonex, we’re constantly innovating to ensure that Maextro not only meets the demands of today but anticipates those of tomorrow.
Bluestonex COO Dan Barton shares, “Data management can feel unremarkable until you see its role in driving compliant, efficient business. Especially now, as AI transforms the pharmaceutical industry, getting MDM right is more critical than ever.”
With Maextro’s latest update, Bluestonex offers pharmaceutical companies the tools they need to elevate their MDM, harness Gen AI’s potential, and drive progress in data quality and compliance.
Discover more about Maextro’s capabilities for life sciences today.
